Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Possible Association Between the Methylenetetrahydrofolate Reductase Gene C677T Polymorphism and Preexisting Portal Vein Thrombosis in Liver Transplant Recipients.

Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation - 1 Jun 2016

Kamei Hideya, Nakamura Taro, Nagai Shunji, Ishigami Masatoshi, Hamajima Nobuyuki

Abstract excerpt

OBJECTIVES: Liver transplant in patients with preexisting portal vein thrombosis involves complicated surgical procedures and increased blood loss, indicating the need for further surgical innovations to overcome these difficulties. Patients who are at high risk of developing portal vein thrombosis may benefit from prophylactic anticoagulant therapy while on the transplant wait list. Homozygosity for C677T...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chi-Square Distribution
Share to Japan

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Liver Cirrhosis

Share to Liver Transplantation

Share to Logistic Models

Share to Methylenetetrahydrofolate Reductase (NADPH2)

Share to Portal Vein

Share to Venous Thrombosis

Source

Identifiers

PMID: 27221722

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Possible Association Between the Methylenetetrahydrofolate Reductase Gene C677T Polymorphism and Preexisting Portal Vein Thrombosis in Liver Transplant Recipients.PMID 27221722Read ↗

Polymorphisms in the methylenetetrahydrofolate reductase gene are determinant for vascular complications after liver transplantation.Semantic proximity Read ↗

Hyperhomocysteinemia and MTHFR C677T polymorphism in patients with portal vein thrombosis complicating liver cirrhosis.Semantic proximity Read ↗

Hepatic artery thrombosis after liver transplantation and genetic factors: prothrombin G20210A polymorphism.Semantic proximity Read ↗

Thrombophilic gene mutations in cirrhotic patients with portal vein thrombosis.Semantic proximity Read ↗

Inherited coagulation disorders in cirrhotic patients with portal vein thrombosis.Semantic proximity Read ↗

Novel insights into the development of portal vein thrombosis in cirrhosis patients.Semantic proximity Read ↗

Causes of portal venous thrombosis in cirrhotic patients: the role of genetic and acquired factors.Semantic proximity Read ↗

Donor factor V Leiden mutation and vascular thrombosis following liver transplantation.Semantic proximity Read ↗

Factor V Leiden mutation is a risk factor for hepatic artery thrombosis in liver transplantation.Semantic proximity Read ↗

Long-term risk of pulmonary embolism in solid-organ transplant recipients.Semantic proximity Read ↗

Coagulation Defects in the Cirrhotic Patient Undergoing Liver Transplantation.Semantic proximity Read ↗

MTHFR C677T polymorphism and risk of HCC in patients with liver cirrhosis: role of male gender and alcohol consumption.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.